Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian D Davis

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Therapeutic Advances in Medical Oncology|April 4, 2022
Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?Ian D Davis
European Urology|June 22, 2025
If the Treatment for Metastatic Hormone-sensitive Prostate Cancer Stops Working, What Next?Ian D Davis
The Lancet. Oncology|November 20, 2016
Challenges of data sharing: valuable but costly?Ian D Davis
Asia-Pacific Journal of Clinical Oncology|November 14, 2014
Advanced renal cell carcinoma in Australia, 2015: what should we do?Ian D Davis
European Urology|June 17, 2026
Re: Transdermal Estradiol Patches in Locally Advanced Prostate CancerIan D Davis
Lancet (London, England)|April 11, 2022
Triplet therapy for prostate cancerIan D Davis
European Urology Oncology|November 3, 2020
Opening a Scan of WormsIan D Davis
JNCI Cancer Spectrum|November 22, 2021
Small Steps and Giant Leaps or Just Getting on With It?Ian D Davis
European Urology|March 12, 2018
Answering Questions and Questioning Answers: More Evidence To Guide Decision-making About Chemohormonal Therapy in Metastatic Prostate CancerIan D Davis
European Urology|October 6, 2022
Be Careful Not To ARAMIS the PointIan D Davis
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Therapeutic Advances in Medical Oncology|April 4, 2022
Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?Ian D Davis
European Urology|June 22, 2025
If the Treatment for Metastatic Hormone-sensitive Prostate Cancer Stops Working, What Next?Ian D Davis
The Lancet. Oncology|November 20, 2016
Challenges of data sharing: valuable but costly?Ian D Davis
Asia-Pacific Journal of Clinical Oncology|November 14, 2014
Advanced renal cell carcinoma in Australia, 2015: what should we do?Ian D Davis
European Urology|June 17, 2026
Re: Transdermal Estradiol Patches in Locally Advanced Prostate CancerIan D Davis
Lancet (London, England)|April 11, 2022
Triplet therapy for prostate cancerIan D Davis
European Urology Oncology|November 3, 2020
Opening a Scan of WormsIan D Davis
JNCI Cancer Spectrum|November 22, 2021
Small Steps and Giant Leaps or Just Getting on With It?Ian D Davis
European Urology|March 12, 2018
Answering Questions and Questioning Answers: More Evidence To Guide Decision-making About Chemohormonal Therapy in Metastatic Prostate CancerIan D Davis
European Urology|October 6, 2022
Be Careful Not To ARAMIS the PointIan D Davis
Pageof 29